Progress towards hematopoietic stem cell gene therapy

Current Opinion in Molecular Therapeutics

Volumn 2, Issue 4, 2000, Pages 400-411

  Kurre, P ^a   Kiem, H P ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

Amphotropic; CD34; Ecotropic; Hematopoietic stem cells; Pseudotyping

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; CD34 ANTIGEN; DRUG; FLT3 LIGAND; MESSENGER RNA; STEM CELL FACTOR; VIRUS VECTOR;

ARTICLE; CHRONIC GRANULOMATOUS DISEASE; CLINICAL TRIAL; COMBINED IMMUNODEFICIENCY; FANCONI ANEMIA; GAUCHER DISEASE; GENE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LENTIVIRINAE; LEUKOCYTE ADHESION DEFICIENCY; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; RETROVIRUS; SPUMA VIRUS; TRANSGENE;

ANIMALS; BIOTECHNOLOGY; CYTOKINES; FANCONI ANEMIA; GAUCHER DISEASE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRANULOMATOUS DISEASE, CHRONIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHIES; HIV INFECTIONS; HUMANS; LENTIVIRUS; NEOPLASMS; RETROVIRIDAE; SEVERE COMBINED IMMUNODEFICIENCY; SPUMAVIRUS;

HUMAN IMMUNODEFICIENCY VIRUS; LENTIVIRUS; SPUMAVIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0033848509     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (118)

1. Retrovirus transfer of a bacterial gene into mouse hematopoietic progenitor cells
2. Introduction of new genetic material into pluripotent hematopoietic stem cells of the mouse
3. Introduction of a selectable gene into primitive stem cells capable of long-term reconstitution of the hemopoietic system of W/W mice
4. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent hematopoietic precursors
5. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation
6. Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation
7. Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: In vivo detection of transduced cells without myeloablation
8. Engraftment of gene-modified umbilical cord blood cells in neonates with adenosine deaminase deficiency
9. Engraftment of hematopoietic progenitor cells transduced with the Fanconi anemia group C gene (FANCC)
10. Gene transfer into hematopoietic stem cells of non-human primates
11. Gene therapy and bone marrow transplantation
12. The level of mRNA encoding the amphotropic retrovirus receptor in mouse and human hematopoietic stem cells is low and correlates with the efficiency of retrovirus transduction
13. Increased gene transfer into human hematopoletic progenitor cells by extended in vitro exposure to a pseudotyped retroviral vector
14. Gene transfer into marrow repopulating cells: Comparison between amphotropic and gibbon ape leukemia virus pseudotyped retroviral vectors in a competitive repopulation assay in baboons
15. Efficient transduction by an amphotropic retrovirus vector Is dependent on high-level expression of the ceil surface virus receptor
16. High-titer packaging ceils producing recombinant retroviruses resistant to human serum
17. Development of improved adenosine deaminase retroviral vectors
18. Efficient gene transfer into canine hematopoietic repopulating cells using RD114 pseudotyped retroviral vectors
19. Characterization of membrane components of the erythrocyte involved in vesicular stomatitis virus attachment and fusion at acidic pH
20. Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: Concentration to very high titer and efficient gene transfer into mammalian and non-mammalian cells
21. A packaging cell line for lentivirus vectors
22. Recombinant retroviruses pseudotyped with the vesicular stomatitis virus G glycoprotein mediate both stable gene transfer and pseudotransduction in human peripheral blood lymphocytes
23. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors
24. Production of high-titer helper-free retroviruses by transient transfection
25. Generation of retroviral vector for clinical studies using transient transfection
26. Expression vectors and delivery systems
27. Centrifugal enhancement of retroviral-mediated gene transfer
28. Increased gene transfer into human cord blood cells by centrifugation-enhanced transduction in fibronectin fragment-coated tubes
29. Consistent and high rates of gene transfer can be obtained using flow-through transduction over a wide range of retroviral titers
30. Stromal support enhances ceil-free retroviral vector transduction of human bone marrow long-term culture-initiating cells
31. Analysis of optimal conditions for retroviral-mediated transduction of primitative human hematopoietic cells
32. Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells
33. Optimization of fibronectin-assisted retroviral gene transfer into human CD34+ hematopoietic cells
34. Improved gene transfer into baboon marrow repopulating cells using recombinant human fibronectin fragment CH-296 in combination with interleukin-6, stem cell factor, Flt-3 ligand and megakaryocyte growth and development factor
35. The use of granulocyte colony-stimulating factor during retroviral transduction on fibronectin fragment CH-296 enhances gene transfer into hematopoietic repopulating cells in dogs
36. Simultaneous infection with retroviruses pseudotyped with different envelope proteins bypasses viral receptor interference associated with colocaiization of gp70 and target cells on fibronectin CH-296
37. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
38. Gene transfer by retrovirus vectors occurs only in cells that are actively replicating at the time of infection
39. Integration of murine leukemia virus DNA depends on mitosis
40. Cell cycle state, response to hemopoietic growth factors and retroviral vector-mediated transduction of human hemopoietic stem cells
41. High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations
42. Comparison of the effects of growth factors on retroviral vector-mediated gene transfer and the proliferative status of human hematopoietic progenitor cells
43. Accelerated cell-cycling of hematopoietic progenitor cells by growth factors
44. Basic fibroblast growth factor Increases retroviral-mediated gene transfer into human hematopoietic peripheral blood progenitor cells
45. Retroviral vector-mediated gene transfer into primitive human hematopoietic progenitor cells: Effects of mast cell growth factor (MGF) combined with other cytokines
46. Combination of interleukins 3 and 6 preserves stem cell function in culture and enhances retrovirus-mediated gene transfer into hematopoietic stem cells
47. Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells
48. T-lymphocytes with a normal ADA gene accumulate after transplantation of transduced autologous umbilical cord blood CD34+ cells in ADA-deficient SCID neonates
49. Prolonged production of NADPH oxidase-corrected granulocytes after gene therapy of chronic granulomatous disease
50. Flt3 ligand preserves the ability of human CD34+ progenitors to sustain long-term hematopoiesis in immune-deficient mice after ex vivo retroviral-mediated transduction
51. Ex vivo expansion of genetically marked Rhesus peripheral blood progenitor cells results in diminished long-term repopulating ability
52. Improved retroviral gene transfer into murine and rhesus peripheral blood or bone marrow repopulating cells primed in vivo with stem cell factor and granulocyte colony-stimulating factor
53. Transduction of non-dividing cells using pseudotyped defective high-titer HIV type 1 particles
54. Efficient transduction of non-dividing human cells by feline immunodeficiency virus lentiviral vectors
55. Stable integration of human immunodeficiency virus-based retroviral vectors into the chromosomes of non-dividing cells
56. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors
57. Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes
58. Cell cycle- and Vpr-mediated regulation of human immunodeficiency virus type 1 expression in primary and transformed T-cell lines
59. A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells
60. Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells
61. Efficient lentiviral transduction of liver requires cell cycling In vivo
62. Learning from lentiviruses
63. Marking and gene expression by a lentivirus vector in transplanted human and non-human primate CD34(+) cells
64. High-efficiency gene transfer into CD34+ cells with a human immunodeficiency virus type 1-based retroviral vector pseudotyped with vesicular stomatitis virus envelope glycoprotein G
65. A third-generation lentivirus vector with a conditional packaging system
66. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery
67. Foamy viruses are unconventional retroviruses
68. Properties of human foamy virus relevant to its development as a vector for gene therapy
69. Helper-free foamy virus vectors
70. Packaging cell lines for simian foamy virus type 1 vectors
71. Eradication of pre-established lymphoma using herpes simplex virus amplicon vectors
72. Development of herpes simplex virus replication-defective multigene vectors for combination gene therapy applications
73. Engineering herpes simplex virus vectors for CNS applications
74. Recombinant adeno-associated virus mediates a high-level of gene transfer but less efficient integration in the K562 human hematopoietic cell line
75. 5 Integrin: A coreceptor for adeno-associated virus type 2 infection
76. Effective gene transfer using viral vectors based on SV40
77. Varied interactions between proviruses and adjacent host chromatin
78. Position-dependent variegation of globin transgene expression in mice
79. Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
80. The mojo of methylation
81. Multiple modifications in cis elements of the long terminal repeat of retroviral vectors lead to increased expression and decreased DNA methylation in embryonic carcinoma cells
82. Novel retroviral vectors for efficient expression of the muitidrug resistance (mdr-1) gene in early hematopoietic cells
83. Host cis-mediated extinction of a retrovirus permissive for expression in embryonal stem cells during differentiation
84. Consistent, persistent expression from modified retroviral vectors in routine hematopoieitic stem cells
85. A GFP reporter system to assess gene transfer and expression in human hematopoietic progenitor cells
86. High levels of lymphoid expression of enhanced green fluorescent protein in non-human primates transplanted with cytokine-mobilized peripheral blood CD34(+) cells
87. Efficient and durable gene marking of hematopoietic progenitor cells in non-human primates after non-ablative conditioning
88. Genetic treatment of severe hemoglobinopathies: The combat against transgene variegation and transgene silencing
89. A 5' element of the chicken β-globin domain serves as an Insulator in human erythroid cells and protects against position effect in Drosophila
90. A chromatin insulator abrogates the negative Impact of position effects on retrovirus vector expression in vivo
91. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix
92. A nuclear DNA attachment element mediates elevated and position-independent gene activity
93. Position-independent transgene expression mediated by boundary elements from the apoiipoprotein B chromatin domain
94. Auten J, Agarwal M, Chen J, Sutton R, Plavec l: Effect of scaffold attachment region on transgene expression in retrovirus vector-transduced primary T-cells and macrophages
95. Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors
96. T-lymphocyte-directed gene therapy for ADA-SCID, initial trial results after 4 years
97. Genetic treatment of the haemogloblnopathies: Recombinations and new combinations
98. The beta-globin LCR is not necessary for an open chromatin structure or developmentally regulated transcription of the native mouse β-globin locus
99. Development of viral vectors for gene therapy of β-chain hemoglobinopathies: Optimization of a γ-globin gene expression cassette
100. An in vitro system for efficiently evaluating gene therapy approaches to hemoglobinopathies
101. Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress
102. Development of safe and efficient retroviral vectors for Gaucher's disease
103. Retrovirus-mediated transfer of the cDNA for human glucocerebrosidase into peripheral blood repopulating cells of patients with Gaucher's disease
104. Transfer of the glucocerebrosidase gene to CD34 cells and their autologous transplantation in patients with Gaucher disease
105. Extended production of oxidase normal neutrophils in X-linked chronic granulomatous disease (CGD) following gene therapy with gp91 (phox) transduced CD34+ cells
106. Somatic mosaicism in Fanconi anemia: Molecular basis and clinical significance
107. Results of mdr-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following Intensive systemic therapy
108. Retroviral-mediated transfer of the human muitidrug resistance gene (mdr-1) into hematopoietic stem cells during autologous transplantation after intensive chemotherapy for metastatic breast cancer
109. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation
110. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients
111. In vivo selection of retrovirally transduced hematopoietic stem cells
112. A gene transfer strategy for making bone marrow cells resistant to trimetrexate
113. Increasing DNA repair methyltransferase levels via bone marrow stem cell transduction rescues mice from the toxic effects of 1,3-bis(2-chloroethyl)-1-nitrosourea, a chemotherapeutic alkylating agent
114. Genetic modification and transplantation of hematopoietic cells for treatment of human immunodeficiency virus Infection
115. A proliferation switch for genetically modified cells
116. Expansion of genetically modified primary human hemopoietic cells using chemical inducers of dimerization
117. Regulated gene expression systems
118. Integrating adenovirus-adeno-associated virus hybrid vectors devoid of all viral genes